MarciaBGoldbergMD

Professor, Medicine-Massachusetts General Hospital, Harvard Medical School

Dr. Goldberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Fruit St
Grj 5
Boston, MA 02114
Phone+1 617-726-3812

Fax+1 617-726-7416

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1986 - 1990
Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1986
Harvard Medical SchoolClass of 1984

PubMed

47 citations
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19.
Paulina Kaplonek, Chuangqi Wang, Yannic C. Bartsch, Stephanie Fischinger, Matthew J. Gorman
Science Immunology. 2021-10-15
11 citations
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses.
Michael S Seaman, Mark J Siedner, Julie Boucau, Christy L Lavine, Fadi Ghantous
Medrxiv. 2022-03-03
223 citations
An immune-cell signature of bacterial sepsis
Miguel Reyes, Michael R. Filbin, Roby P. Bhattacharyya, Kianna Billman, Thomas Eisenhaure
Nature Medicine. 2020-02-17

Other

Treatment and prevention of Shigella infection in adults
Goldberg MB, Agha R
http://www.uptodate.com/contents/treatment-and-prevention-of-shigella-infection-in-adults
UpToDate, Wolters Kluwer Health - 2013-03-13
Clinical manifestations and diagnosis of Shigella infection
Goldberg MB, Agha R
http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-shigella-infection
UpToDate, Wolters Kluwer Health - 2012-04-11
Epidemiology, microbiology, and pathogenesis of Shigella infection
Goldberg MB
http://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-shigella-infection
UpToDate, Wolters Kluwer Health - 2012-08-21

Molecular Signaling In Shigella DisseminationNational Institute Of Allergy And Infectious Diseases2010–2012
Career Development In BiodefenseNational Institute Of Allergy And Infectious Diseases2009–2012
Shigella Regulation Of N-WASP Mediated Actin AssemblyNational Institute Of Allergy And Infectious Diseases2009–2010
Develop Antibiotics That Inhibit Bacterial Virulence ProteinsNational Institute Of Allergy And Infectious Diseases2009–2010
Molecular Signaling In Shigella DisseminationNational Institute Of Allergy And Infectious Diseases2009
Mechanisms Of Shigella Intercellular SpreadNational Institute Of Allergy And Infectious Diseases2008–2009
Mechanism And Function Of Unipolarity Of Shigella ICSANational Institute Of Allergy And Infectious Diseases2000–2009
Shiga Toxin-Encoding Phage Adsorption And Toxin ReleaseNational Institute Of Allergy And Infectious Diseases2006–2007
Function Of Virk And Msbb2 In Shigella PathogenesisNational Institute Of Allergy And Infectious Diseases2005–2006
Autotrasporter Periplasmic Chaperones In ShigellaNational Institute Of Allergy And Infectious Diseases2004–2005
Shigella Pathogenesis Relevant To Protective ImmunityNational Institute Of Allergy And Infectious Diseases1999–2003
Shigella Pathogenesis Relevant To Protective ImmunityNational Institute Of Allergy And Infectious Diseases1999
Macrophage Cytoskeleton-Based Movement Of ShigellaNational Institute Of Allergy And Infectious Diseases1994–1998